Complement activation by cross-linked truncated and chimeric full- length β-amyloid

NeuroReport

Volumn 8, Issue 16, 1997, Pages 3457-3462

  Cribbs, David H ^a   Velazquez, Peter ^b   Soreghan, Brian ^b   Glabe, Charles G ^b   Tenner, Andrea J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; C1q; Chimeric peptides; Complement activation; Cross linked; Inflammatory response; Thioflavine

Indexed keywords

AMYLOID BETA PROTEIN; THIOFLAVINE;

AGING; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CHIMERA; COMPLEMENT ACTIVATION; CROSS LINKING; DRUG RECEPTOR BINDING; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN;

EID: 0030663630     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199711100-00009     Document Type: Article

References (29)

1. Eikelenboom P and Slam FC. Acta Neuropathol 57, 239-242 (1982).
2. Eikelenboom P, Hack CE, Rozemuller JM and Stam FC, Virchows Arch B Cell Pathol Mol Pathol 56, 259-262 (1989).
3. Eikelenboom P, Hack CE, Kamphorst W and Rozemuller JM. Res Immunol 143, 617-620 (1992).
4. McGeer PL, Akiyama H, Itagaki S and McGeer EG. Can J Neurot Sci 16, 516-527 (1989).
5. McGeer PL and McGeer EG. Res Immunol 143, 621-624 (1992).
6. Afagh A, Cummings BJ, Cribbs DH et al. Exp Neurol 138, 22-32 (1996).
7. Webster S, Lue L F, Brachova L et al. Neurobiol Aging in press (1997).
8. Yao J, Harvath L, Gilbert DL and Colton CA. J Neurosci Res 27, 36-42 (1990).
9. Eikelenboom P, Zhan SS, van Gool WA and Allsop D. Trends Pharmacol Sci 15, 447-450 (1994).
10. Eikelenboom P and Veerhuis R. Neurobiol Aging 17, 673-680 (1996).
11. Cotman CW, Tenner AJ and Cummings BJ. Neurobiol Aging 17, 723-731 (1996).
12. McGeer PL, McGeer E, Rogers J and Sibley J. Lancet 335, 1037 (1990).
13. Rogers J, Kirby LC, Hempelman SR et al. Neurology 43, 1609-1611 (1993).
14. Van Muiswinkel FL and Eikelenboom P. Drugs Aging 9, 1-7 (1996).
15. Stewart WF, Kawas C, Corrada M and Metter EJ. Neurology 48, 626-632 (1997).
16. Rogers J, Cooper NR, Webster S et al. Proc Natl Acad Sci USA 89, 10016-10020 (1992).
17. Jiang H, Burdick D, Glabe CG et al. J Immunol 152, 5050-5059 (1994).
18. Webster S, Bradt B, Rogers J and Cooper N. J Neurochem in press (1997).
19. Soreghan B, Kosmoski J and Glabe C. J Biol Chem 269, 28551-28554 (1994).
20. Burdick D, Soreghan B, Kwon M et al. J Biol Chem 267, 546-554 (1992).
21. Schagger H and von Jagow G. Anal Biochem 166, 368-379 (1987).
22. Cribbs DH, Pike CJ, Weinstein SL et al. J Biol Chem 272, 7431-7436 (1997).
23. Velazquez P, Cribbs DH. Poulos TL and Tenner AJ. Nature Med 3, 77-79 (1997).
24. Selkoe DJ. J Neuropathol Exp Neurology 53, 438-447 (1994).
25. Rozemuller JM, Eikelenboom P, Stam FC et al. J Neuropathol Exp Neurol 48, 674-691 (1989).
26. Kirschner DA, Inouye H, Duffy LK et al. Proc Natl Acad Sci USA 84, 6953-6957 (1987).
27. Loo DT, Copani A, Pike CJ et al. Proc Natl Acad Sci USA 90, 7951-7955 (1993).
28. Cotman CW and Anderson AJ. Mol Neurobiol 10, 19-45 (1995).
29. Moller T, Nolte C, Burger R et al. J Neurosci 17, 615-624 (1997).